NL-OMON55237已完成不适用
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF (PULSED AF) - PULSED AF study
Medtronic BV0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •A diagnosis of recurrent symptomatic paroxysmal or persistent AF with failure
- •of at least one AAD (class I or III) for AF as evidenced by recurrent
- •symptomatic AF, or intolerable side effects due to AAD.
排除标准
- •Long-standing persistent AF (continuous AF that is sustained >12 months)
- •Patient who is not on oral anticoagulation therapy for at least 3 weeks prior
- •to the ablation procedure
研究者
相似试验
已完成
3 期
Pulsed Field Ablation to Irreversibly Electroporate Tissue and Treat AF (PULSED AF)JPRN-jRCT2052210035Shiomitsu Aki400
已完成
2 期
Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma - a multicenter phase I/II safety studyKlatskin tumorperihilar bile duct tumorPerihilar cholangiocarcinoma10019654NL-OMON50469Academisch Medisch Centrum12
尚未招募
不适用
Irreversible electroporation (NanoKnife) for advanced perihilar cholangiocarcinomacholangiocarcinomaNL-OMON25184Academic Medical Center (AMC)20
进行中（未招募）
1 期
Irreversible electroporation (NanoKnife) in combination with immunotherapy for non-curable pancreatic cancerPatients with non-curable pancreatic cancerMedDRA version: 20.0Level: LLTClassification code 10033575Term: Pancreas cancerSystem Organ Class: 100000004864EUCTR2020-004623-17-DKZealand University Hospital12
已完成
不适用
esion Characteristics after Pulsed-Field Ablation in Patients with Atrial Fibrillation and a Left Common Ostium (PFALCO RE-MAP STUDY)10007521Atrial fibrillationNL-OMON56175OLVG24